We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.28B
AUM Growth
-$23.7M
Cap. Flow
-$14.6M
Cap. Flow %
-1.14%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$3.58M
2
STAA icon
STAAR Surgical
STAA
+$2.29M

Top Sells

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$20.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 34.06%
2 Industrials 33.54%
3 Healthcare 23.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$436M 34.06%
8,295,690
– –
AXON
2
Axon Enterprise
AXON
$42.5B
$429M 33.54%
722,421
-37,641
-5% -$20.5M
STAA icon
3
STAAR Surgical
STAA
$1.21B
$264M 20.59%
10,848,631
+80,200
+0.7% +$2.29M
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$115M 8.98%
519,920
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$20.9M 1.64%
41,666,255
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$14.9M 1.16%
6,244,405
+1,315,339
+27% +$3.58M
SER icon
7
Serina Therapeutics
SER
$30M
$427K 0.03%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Broadwood Capital held 7 positions worth $1.28B, down 1.8% from $1.3B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q4 2024, an estimated $3.58M increase.
  • Broadwood Capital's biggest Q4 2024 reduction was Axon Enterprise, cutting an estimated $20.5M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.28B portfolio in Q4 2024.
  • Broadwood Capital opened 0 new positions and closed 0 in Q4 2024.
  • Broadwood Capital's portfolio value fell 1.8% quarter-over-quarter to $1.28B.

Based on Broadwood Capital's 13F filing for Q4 2024, filed 14 Feb 2025.